I took my last doses of Esbriet the day before I received my bilateral lung transplant in July 2021. That, however, did not put an end to my sun sensitivity. I was now sensitive to the sun for a ...

A Texas researcher received a $219,000 NIH grant to study the potential of a treatment for radiation-induced pulmonary ...

Clinical trials are an important part of IPF research, says columnist Sam Kirton, but we need people willing to participate in them.

The goal of PFF Walk 2025 is to raise at least $1.02 million, according to a foundation webpage. The campaign has already reached 40% of this goal. “While PF is a debilitating lung disease, our ...

One of my frustrations as a pulmonary fibrosis patient is finding solid information about what to expect as my PF progresses. I’ve asked several doctors what to expect during the end stage of PF, but ...

Esbriet (pirfenidone) is an oral treatment for idiopathic pulmonary fibrosis (IPF) that is known to decrease inflammation by reducing the synthesis of a pro-inflammatory molecule called transforming ...

“Following productive FDA interactions and positive top-line results from the Phase 1b trial, we have designed our RENEW trial to test the promise of our dual mechanism approach to targeting alveolar ...

Patients were assigned randomly to receive either 30 or 60 mg of the therapy, or a placebo, taken twice a day, for about six months. Background use of antifibrotics or select immunosuppressive ...

My chronic illness also prevents me from achieving milestones that my peers are having. For my age, young adulthood, these typically include engagements, weddings, and starting a family. Even if IPF ...